CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth takes a stake in T2S

CDG Invest Growth takes a stake in T2S (Techniques Science Santé), Morocco’s leading distributor of high tech medical equipment.

T2S, the leader in the distribution and the maintenance of medical equipment

Founded in 1992, T2S assists healthcare professionals in the installation, training for utilisation and maintenance of high technology medical equipment. T2S distributes in Morocco products from General Electric Healthcare, Varian Medical Systems, Zeiss, B Braun, Getinge, Aesculap as well as other brands.  Since its creation, T2S has built a strong reputation in radiology (scanners, MRIs…) and oncology (linacs for radiotherapy) and has today the largest installed base in Morocco in high tech medical equipment.

The company has historically built its reputation in the nineties by assisting private doctors in opening their first medical offices and has accompanied these same doctors when they opened larger clinics.  It is now the preferred partner of healthcare professionals for their development projects.

With its large product range, T2S can now propose turnkey solutions for multi-specialty clinics and hospitals and can therefore provide a one stop shop solution for its customers, from the planning of the site, the installation of the equipment, the training of the teams and eventually the maintenance.

In Morocco, T2S has participated in several structural health projects both on the public and private side, including several CHUs (centres hospitaliers universitaires) as well as large hospitals built by international foundations (Fondation Cheikh Khalifa Ibn Zaid in Casablanca and Fondation Cheikh Zaid in Rabat).

African Track Record

Since 2008, T2S has expanded outside Morocco and has equipped the first radiotherapy, oncology and nuclear medicine center in Mauritania.  This successful experience enabled the company to equip other medical centers in Mauritania with radiology equipment.  T2S is also active in Ivory Coast and Mali and is currently exploring new opportunities in other African countries.

A partnership to strengthen the company

The company has the ambition to pursue its growth and further cement its leadership position. Abderraouf Sordo, the founder and CEO of T2S said “We are very optimistic about the outlook of the healthcare sector in our region and the role of medical equipment to succeed. Our partnership with CDG Invest Growth will give us an institutional investor as well as a hands-on partner that will help us achieve our growth and development targets”

Brahim Guessous, Partner at CDG Invest Growth who lead the deal commented “we have been impressed by what has been accomplished by this great team over the last 25 years. In the context of the liberalisation of the healthcare sector in Morocco and the opportunities we see in Africa, we are confident in the growth potential of T2S.  With already high ESG standards, this company can continue to play a key role in the development of the healthcare industry, thereby impacting positively the communities it serves”.

In 2015, T2S made c.€40m of annual turnover and had 140 employees. CDG Invest Growth took a minority stake in T2S.

Click here for more information about T2S

January 2019 CDG Invest Growth, the private equity firm focused on growth investments for SMEs in Morocco, announced an investment in Laboratoires Steripharma (“Steripharma” or “the Company”), a well-established pharmaceutical business in Morocco. CDG Invest Grwoth has acquired a stake in the Company from several minority shareholders. Steripharma was founded in 1999 and has since developed […]

In December 2014, CDG Invest Growth exited JUICE AND NECTAR PARTNERS (JNP), the latest investment of the Accès Capital Atlantique Maroc S.A (ACAMSA) Fund.The withdrawal of JNP, a producer of organic juice mainly for export, was carried out to the benefit of the HOLMARCOM Group, a major operator in the Moroccan economy. This sale operation […]

CDG Invest Growth, a leading Morocco based private equity firm, invests in Soludia Maghreb, the leading provider of haemodialysis products and other related drugs in Morocco, through the acquisition of a significant minority stake. Founded in 1998 by Dr Abdelaziz Razkaoui after a successful technology transfer from Soludia France, Soludia Maghreb has become a leader […]